0001209191-12-042119.txt : 20120816
0001209191-12-042119.hdr.sgml : 20120816
20120816143100
ACCESSION NUMBER: 0001209191-12-042119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120815
FILED AS OF DATE: 20120816
DATE AS OF CHANGE: 20120816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN JACK
CENTRAL INDEX KEY: 0001230729
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 033-80623
FILM NUMBER: 121039645
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000949858
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 954343413
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1522 217TH PLACE S.E.
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254879500
MAIL ADDRESS:
STREET 1: 1522 217TH PLACE S.E.
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950825
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2012-08-15
0
0000949858
ONCOGENEX PHARMACEUTICALS, INC.
OGXI
0001230729
GOLDSTEIN JACK
1522 217TH PLACE SE
SUITE 100
BOTHELL
WA
98021
1
0
0
0
Common Stock
2012-08-15
4
P
0
1000
14.381
A
1000
D
Sandra Thomson as attorney-in-fact for Jack Goldstein
2012-08-16